DRF-1042 is an orally active camptothecin derivative that inhibits DNA topoisomerase I. It exhibits strong anticancer activity against various human cancer cell lines, including those with multi-drug resistance (MDR), and has cytotoxic effects. Reagent grade, for research purpose.
Usually ships within 24 hours.